Pleiotropic effects of thiazolidinediones

Expert Opinion on Pharmacotherapy
C V RizosM S Elisaf

Abstract

Insulin resistance and hyperglycemia characterize type 2 diabetes mellitus. Type 2 diabetes mellitus is usually accompanied by concomitant disorders, such as dyslipidemia, hypertension and atherosclerosis. Thiazolidinediones are antidiabetic drugs that increase insulin sensitivity by activating the peroxisome proliferator-activated receptor gamma. There is evidence that thiazolidinediones exert a number of pleiotropic effects that may play an important role in the treatment of type 2 diabetes mellitus. The purpose of the present article was to review the 'pleiotropic' effects of thiazolidinediones (i.e., their effects beyond glucose lowering). The study involved searching PubMed up to February 2008 using relevant keywords. Thiazolidinediones favorably alter fat distribution and improve cardiovascular risk factors, such as blood pressure, inflammation markers and uric acid and they may also delay the progression of atherosclerosis. The effects on the lipid profile differ between the two thiazolidinediones studied with pioglitazone having more positive effects compared with rosiglitazone. Furthermore, thiazolidinediones improve diabetic complications, such as diabetic nephropathy and non-alcoholic fatty liver disease. Thiazolidin...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J SchneidermanD J Loskutoff
Dec 4, 1991·JAMA : the Journal of the American Medical Association·F FacchiniG M Reaven
Oct 1, 1989·Hypertension·A P RocchiniM Gregory
May 1, 1984·Diabetes Care·P I SalmelaO Mäentausta
Aug 1, 1996·American Journal of Hypertension·E MuscelliE Ferrannini
Oct 15, 1996·The Journal of Clinical Investigation·R E LawW A Hsueh
Dec 27, 1996·Annals of the New York Academy of Sciences·B M FormanR M Evans
Feb 21, 1998·Annals of Internal Medicine·H N HodisS P Azen
Jan 23, 1999·The American Journal of Cardiology·S M Marcovina, M L Koschinsky
Sep 1, 1999·Current Opinion in Hematology·A D Michelson, M I Furman
Aug 12, 2000·Prostaglandins & Other Lipid Mediators·T HishinumaM Mizugaki
Aug 23, 2000·The Journal of Clinical Investigation·H N Ginsberg
Sep 9, 2000·Archives of Internal Medicine·E GrossmanU Goldbourt
Nov 23, 2000·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·G ChinettiB Staels
Nov 30, 2000·Biochemical and Biophysical Research Communications·J SakamotoH Sawada
Dec 21, 2000·Trends in Pharmacological Sciences·G J Murphy, J C Holder
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Jun 8, 2001·Annual Review of Biochemistry·T M WillsonS A Kliewer

❮ Previous
Next ❯

Citations

Mar 3, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·R Ferrer-LorenteM Alemany
Mar 19, 2013·European Journal of Pharmacology·Christos V Rizos, Moses S Elisaf
Mar 20, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jorge E ToblliNestor F Gonzalez-Cadavid
Apr 17, 2009·The Journal of Pharmacology and Experimental Therapeutics·Rajani KaimalRuitang Deng
Dec 17, 2008·Pharmacological Reviews·Wook Kim, Josephine M Egan
Oct 6, 2010·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Yongqing Yang, Gongshe Yang
Dec 4, 2009·QJM : Monthly Journal of the Association of Physicians·E Erdmann, R Wilcox
May 23, 2013·Expert Opinion on Therapeutic Targets·Manfredi RizzoAli A Rizvi
Jan 30, 2013·Expert Opinion on Therapeutic Targets·Sana KhanAbul Kalam Najmi
Jun 19, 2009·Expert Opinion on Therapeutic Targets·Evan RosenZhao Xu
Mar 29, 2011·Expert Review of Cardiovascular Therapy·Aris P AgouridisMoses S Elisaf
Feb 25, 2009·Expert Opinion on Drug Safety·C V RizosE N Liberopoulos
Jun 24, 2008·Expert Opinion on Pharmacotherapy·M FlorentinM S Elisaf
Jun 10, 2011·Expert Opinion on Pharmacotherapy·Nikolaos PapanasEfstratios Maltezos
Oct 22, 2015·In Vitro Cellular & Developmental Biology. Animal·Fang DingJiwen Wang
Oct 10, 2009·Metabolism: Clinical and Experimental·Nikolaos P E KadoglouNikolaos Sailer
Sep 16, 2010·Cardiovascular Therapeutics·Pantelis A SarafidisAnastasios N Lasaridis
Jul 17, 2014·Seizure : the Journal of the British Epilepsy Association·Niki KatsikiDevaki R Nair
May 14, 2010·Postgraduate Medicine·Annie A MavianRobert R Henry
Apr 8, 2016·Current Medical Research and Opinion·Christos V Rizos, Moses S Elisaf
Oct 30, 2012·Bioorganic & Medicinal Chemistry Letters·Letizia GiampietroRosa Amoroso
May 12, 2016·Archives of Toxicology·Christos V RizosMoses S Elisaf
Oct 4, 2012·Journal of Cardiovascular Medicine·Niki KatsikiDimitri P Mikhailidis
Oct 13, 2011·Angiology·Niki KatsikiDimitrios T Karamitsos
Apr 7, 2011·Angiology·Sanja S SoskićEsma R Isenović
Oct 15, 2018·Journal of Cellular Physiology·Yaser KhajebishakBeitollah Alipour
Jan 23, 2009·The Journal of Clinical Endocrinology and Metabolism·Elmar AignerChristian Datz
Jun 10, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Dorte Glintborg, Marianne Andersen
May 6, 2019·Endocrine Reviews·Antonino Di Pino, Ralph A DeFronzo
Jun 3, 2018·Hormones : International Journal of Endocrinology and Metabolism·Panagiotis AnagnostisAsterios Karagiannis
Oct 10, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Liliana Monica BivolBjarne M Iversen
Jan 23, 2021·Biomedicines·Carlos M González-CasimiroGermán Perdomo
Mar 27, 2021·The Journal of Clinical Endocrinology and Metabolism·Jiahao ZhuYingjun Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.